BioMarin Pharmaceutical 10K 2023 Annual report | BMRN Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abbisko, activist, adequacy, affirmative, affirmed, Ajer, Alexander, anderson, appetite, aseptic, athena, backup, Barbara, belonging, binding, Bodem, boost, burkhart, CE, CFO, chair, Commerce, coordination, CRC, david, disaggregated, disqualifying, distraction, DOJ, ECC, elizabeth, Elliott, entry, enyedy, erin, ERP, Evox, exemption, experimental, exploited, FIFO, fifteen, finite, gather, gathering, geopolitical, Haemophilia, hardware, Hardy, Head, ho, hosted, hosting, HTA, hypochondroplasia, idiopathic, Immunoforge, ineffective, installed, investor, Jeffrey, join, legacy, maykin, mckee, mentorship, modestly, momentum, morale, negligible, NIST, onboarding, oncology, Organisation, outpaced, oversee, overseeing, Parliament, pen, Peptron, PMA, Poseida, preliminarily, proffered, proof, pyott, reactive, Registry, reply, ROCTAVIANTM, Ruble, Russian, scrutinize, SiSaf, societal, step, stipulation, subpoena, supranational, terrorism, Tessera, threatened, tooling, toxicology, Tyra, undergo, unrecoverable, unreliable, unusual, vacating, vendor, violence, vitro, war

Removed: ABR, agent, assay, Asubio, beneficiary, blinded, Borrower, certainty, chromogenic, Citibank, commissioned, Conference, corticosteroid, cultural, cut, deducted, defend, dere, dosed, electric, Escrow, Fargo, Fenner, foramen, fostering, Gas, Harmonisation, height, heightened, Homology, incorporate, Inducement, Irish, label, lender, LogicBio, Lynch, magnum, main, meal, median, merit, Merrill, mirror, missed, molecule, participant, perspective, Pierce, placebo, precisely, prophylactic, purpose, refuse, regimen, relied, remotely, Repurchased, resubmission, RNA, rollover, Sangamo, Sankyo, shelf, showed, Smith, sparked, SR, steadfast, substrate, Swing, terminal, thereunder, thromboembolic, tolerated, topline, transient, unqualified, unregistered, usage, utility, varied, VIE, Washington, weakening, widespread, willard, wind

BioMarin Pharmaceutical (BMRN) 10-K2023 FY Annual report

Content analysis